Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 529

    1.

    Transgenic insulin (B:9-23) T-cell receptor mice develop autoimmune diabetes dependent upon RAG genotype, H-2g7 homozygosity, and insulin 2 gene knockout.

    Jasinski JM, Yu L, Nakayama M, Li MM, Lipes MA, Eisenbarth GS, Liu E.

    Diabetes. 2006 Jul;55(7):1978-84.PMID: 16804066 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice.

    Verdaguer J, Schmidt D, Amrani A, Anderson B, Averill N, Santamaria P.

    J Exp Med. 1997 Nov 17;186(10):1663-76.PMID: 9362527 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    CD4(+) T cells from glutamic acid decarboxylase (GAD)65-specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transfer.

    Tarbell KV, Lee M, Ranheim E, Chao CC, Sanna M, Kim SK, Dickie P, Teyton L, Davis M, McDevitt H.

    J Exp Med. 2002 Aug 19;196(4):481-92.PMID: 12186840 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Major histocompatibility complex class II molecules can protect from diabetes by positively selecting T cells with additional specificities.

    Lühder F, Katz J, Benoist C, Mathis D.

    J Exp Med. 1998 Feb 2;187(3):379-87.PMID: 9449718 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Activation of insulin-reactive CD8 T-cells for development of autoimmune diabetes.

    Wong FS, Siew LK, Scott G, Thomas IJ, Chapman S, Viret C, Wen L.

    Diabetes. 2009 May;58(5):1156-64. Epub 2009 Feb 10.PMID: 19208910 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    T-cell receptor transgenic response to an endogenous polymorphic autoantigen determines susceptibility to diabetes.

    Pauza ME, Dobbs CM, He J, Patterson T, Wagner S, Anobile BS, Bradley BJ, Lo D, Haskins K.

    Diabetes. 2004 Apr;53(4):978-88.PMID: 15047613 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice.

    Nakayama M, Abiru N, Moriyama H, Babaya N, Liu E, Miao D, Yu L, Wegmann DR, Hutton JC, Elliott JF, Eisenbarth GS.

    Nature. 2005 May 12;435(7039):220-3.PMID: 15889095 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice.

    You S, Slehoffer G, Barriot S, Bach JF, Chatenoud L.

    Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2:14580-5. Epub 2004 Aug 30.PMID: 15340148 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    RAG-dependent peripheral T cell receptor diversification in CD8+ T lymphocytes.

    Serra P, Amrani A, Han B, Yamanouchi J, Thiessen SJ, Santamaria P.

    Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15566-71. Epub 2002 Nov 13.PMID: 12432095 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    RIP-beta 2-microglobulin transgene expression restores insulitis, but not diabetes, in beta 2-microglobulin null nonobese diabetic mice.

    Kay TW, Parker JL, Stephens LA, Thomas HE, Allison J.

    J Immunol. 1996 Oct 15;157(8):3688-93.PMID: 8871671 [PubMed - indexed for MEDLINE]Related articles

    12.

    CD4 T cells play major effector role and CD8 T cells initiating role in spontaneous autoimmune myocarditis of HLA-DQ8 transgenic IAb knockout nonobese diabetic mice.

    Hayward SL, Bautista-Lopez N, Suzuki K, Atrazhev A, Dickie P, Elliott JF.

    J Immunol. 2006 Jun 15;176(12):7715-25.PMID: 16751419 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Immunogenetic analysis of beta-cell autoimmunity in NOD mice. Relationship of insulitis to T-lymphocyte-receptor beta nod and A beta nod genes.

    Winter WE, Shimpo K, Obata M, Yamada K, Luchetta R.

    Diabetes. 1990 Aug;39(8):975-82.PMID: 1973674 [PubMed - indexed for MEDLINE]Related articles

    14.

    PD-1 deficiency reveals various tissue-specific autoimmunity by H-2b and dose-dependent requirement of H-2g7 for diabetes in NOD mice.

    Yoshida T, Jiang F, Honjo T, Okazaki T.

    Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3533-8. Epub 2008 Feb 25.PMID: 18299579 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells.

    Kim SK, Tarbell KV, Sanna M, Vadeboncoeur M, Warganich T, Lee M, Davis M, McDevitt HO.

    Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14204-9. Epub 2004 Sep 20.PMID: 15381770 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Genetic analysis of diabetes in the nonobese diabetic mouse. I. MHC and T cell receptor beta gene expression.

    Livingstone A, Edwards CT, Shizuru JA, Fathman CG.

    J Immunol. 1991 Jan 15;146(2):529-34.PMID: 1824775 [PubMed - indexed for MEDLINE]Related articles

    18.

    Regulatory and effector CD4 T cells in nonobese diabetic mice recognize overlapping determinants on glutamic acid decarboxylase and use distinct V beta genes.

    Quinn A, McInerney B, Reich EP, Kim O, Jensen KP, Sercarz EE.

    J Immunol. 2001 Mar 1;166(5):2982-91.PMID: 11207247 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Cross-priming of diabetogenic T cells dissociated from CTL-induced shedding of beta cell autoantigens.

    Yamanouchi J, Verdaguer J, Han B, Amrani A, Serra P, Santamaria P.

    J Immunol. 2003 Dec 15;171(12):6900-9.PMID: 14662897 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction.

    Chong MM, Chen Y, Darwiche R, Dudek NL, Irawaty W, Santamaria P, Allison J, Kay TW, Thomas HE.

    J Immunol. 2004 May 1;172(9):5714-21.PMID: 15100317 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data